Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Top ETF Stories Of November

Published 12/03/2019, 02:30 AM

The Wall Street was upbeat last month on trade optimism, moderate earnings and a strong start to the holiday season despite subdued consumer confidence data. SPDR S&P 500 ETF Trust (ASX:SPY) added 3.3% in the month and SPDR Dow Jones Industrial Average (NYSE:DIA) ETF Trust (TSXV:DIA) andInvesco QQQ Trust QQQ jumped 4.1% each (read: What Soft Confidence? 3 ETFs & Stocks for Solid Holiday Buying).

Against this backdrop, we highlight the key ETF events of last month.

Wall Street at All-Time High

U.S. stocks have been rallying since the news of the phase-one U.S.-China trade deal emerged in October. The rally picked up in November on President Trump’s announcement that the U.S. and Chinese negotiators were "close" to a "phase one" trade deal. The key U.S. equity indexes hit fresh records multiple times in the month. SPY hit a high of $315.48 at month-end while QQQ hit a high of $206.05 on Nov 27.

Ebb and Flow of Trade Tensions

The month was all about the ebb and flow of U.S.-China trade tensions. While on one hand, Trump called the initial level of a trade deal close, the U.S. President signed a bill in support of Hong Kong protesters which undermined China’s interests. As a result, all trade-sensitive securities saw some volatility in the month. Overall, iShares China Large-Cap ETF (TE:FXI) has lost about 3.7% in the past month (as of Dec 2, 2019).

Not all was dicey on the trade front. Another trade negotiation hogged investors’ attention — the United States-Mexico-Canada (USMCA) deal. Speaker Nancy Pelosi said on Nov 25 that the deal is ‘within range’ and House Democrats and the Trump administration have resolved their issues on the USMCA but a final review is still to be done(read: USMCA Trade Deal 'Within Range': ETFs to Benefit).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This puts focus on Mexico and Canada ETFs like iShares MSCI Mexico Capped ETF EWW and iShares MSCI Canada ETF (ASX:EWC) .

Healthcare Sector Tops

FDA approvals, solid merger-acquisition environment and positive drug data have made the healthcare sector a star performer in November. Virtus LifeSci Biotech Clinical Trials ETF (ASX:BBC) and iShares U.S. Healthcare Providers ETF IHF are some of the top performers in the space (read: Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD).

Online Shopping on the Rise

A six-day shorter holiday shopping season this year led retailers to come up with deals earlier than usual, which drove the retail sales numbers in November. Online sales for Thanksgiving and Black Friday rose 17% year over year, according to Adobe (NASDAQ:ADBE) Analytics. Black Friday online sales hit a record $7.4 billion this year. ProShares Online Retail ETF (NASDAQ:ON) is a clear winner given the trend. Also, VanEck Vectors Retail ETF (TSXV:RTH) grabs attention as it has wide exposure to winning retail companies like Wal-Mart (NYSE:WMT) and Target (NYSE:TGT) .

Marijuana Crash

Downbeat earnings dealt a blow to the marijuana space in November. However, amid an awful earnings scenario, the marijuana space turned around in mid-November on bill hopes. Shares of marijuana companies rose on Nov 21 after a U.S. congressional committee passed a legislation that would end the federal embargo on weed (read: Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?).

The latest bill will enact a 5% federal sales tax on marijuana products that are manufactured in or imported into the United States and obliterate past criminal records. Analysts are still doubtful about the near-term prospects of the space. The sponsors of the bill warned that the Senate was unlikely to approve it anytime soon.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Overall, marijuana ETFs like ETFMG Alternative Harvest ETF (CSE:MJ) , Global X Cannabis ETF (BO:POTX) and Amplify Seymour Cannabis ETF CNBS lost about13.6%, 16.2% and 12%, respectively, in the past month.

Alibaba’s Grand Hong Kong Debut

Chinese e-commerce giant Alibaba Group (NYSE:BABA) made a blockbuster Hong Kong debut in late November, with the stock rising 7%. The company's “secondary listing could raise as much as $12.9 billion, making it the largest public offering so far this year.” Alibaba’s Hong Kong shares, trading under the stock code 9988, will be added to the Hang Seng Composite Index on Dec 9 (read: ETFs to Tap Alibaba's Stunning Hong Kong Debut).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



Alibaba Group Holding Limited (BABA): Free Stock Analysis Report

SPDR Dow Jones Industrial Average

VanEck Vectors Retail ETF (RTH): ETF Research Reports

iShares MSCI Canada ETF (EWC): ETF Research Reports

iShares China Large-Cap ETF (FXI): ETF Research Reports

Virtus LifeSci Biotech Clinical Trials ETF (BBC): ETF Research Reports

iShares MSCI Mexico ETF (EWW): ETF Research Reports

iShares U.S. Healthcare Providers ETF (IHF): ETF Research Reports

Invesco QQQ (QQQ): ETF Research Reports

SPDR S&P 500 ETF (NYSE:SPY

Target Corporation (TGT): Free Stock Analysis Report

Walmart Inc. (WMT): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Global X Cannabis ETF (POTX): ETF Research Reports

ETFMG Alternative Harvest ETF (MJ): ETF Research Reports

Amplify Seymour Cannabis ETF (CNBS): ETF Research Reports

ON Semiconductor Corporation (ON): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.